A recent news article on ABCnews.com reported that “..... Many of our body's internal processes are cyclical. There are daily patterns, such as awakening and sleep, menstrual patterns, such as the woman’s menstrual cycle, and even seasonal patterns, such as those that cause seasonal affective disorder (SAD) during the winter months. But doctors have only recently begun to understand the effect of these rhythms on other conditions well enough to treat their patients more effectively. those that are improved depending on when they are given to the patient are called chronotherapy. And using this good time, doctors find that they more effectively treat a wide range of diseases, such as asthma, arthritis and cancer, while reducing the side effects of the consequences. "
According to Dr. Michael Smolensky, co-author of the book “Watchmaker's Guide to Better Health”: “When cancer drugs are prescribed in a chronobiological manner, patients can tolerate higher, more powerful doses than would otherwise be possible.”
Keith Block, MD, one of the leading experts in the field of cancer, has been using chronotherapy with her patients since 1999. “This method of chemotherapy is revolutionary and has shown in large randomized studies its potential for improving survival,” says Dr. Blok, Dr. Block, who is also the medical / scientific director of the Block Center for Comprehensive Cancer Treatment and Optimal Health in Evanston, Illinois. “Current research shows that Cis-Platin is best given between 4 and 6 in the evening, rather than in the evening, as reported in the ABC News article. Adriamycin should peak at 4 am with an infusion window of 4-6 am. found that often patients receiving chronotherapy reduce what would be the recurring side effects of nausea, vomiting, diarrhea and fatigue. This is important because debilitation caused by chemotherapy can cause patients to reduce or even stop treatment, which otherwise could help them win the battle with cancer. ”
Randy Lopez was diagnosed with advanced colon cancer at 35 years old. Struggling for his life, he underwent chemotherapy, which left him weak and weak. Less than a year later, he received more devastating news - the cancer metastasized to the liver. The forecast was grim. In fact, Lopez and his doctors believed that he did not have enough time. After working with Dr. Block and undergoing chronotherapy, Lopez, who is now 42 years old, without cancer. He will visit the National Colon Cancer Alliance (CCA) in New York on September 30, where Dr. Block will review the CCA and explain that although the time was not on Randy's side, timing was literally the key to his successful recovery. .
One of the main problems with this type of treatment was logistics - figuring out how to deliver chemotherapy to exactly calculated doses. Dr. Block introduced technology in the USA that manages chemotherapy with a pump designed for the exact time of up to four infusion channels simultaneously with the individual needs of the patient. Highly portable and small enough to fit into a fanny package, patients can maintain full mobility, play sports and enjoy a full night's sleep - when they receive their specially prescribed cancer therapy.
Keith I. Block, MD is co-founder and physician / supervisor of the Block Center for Comprehensive Cancer Treatment and Optimal Health in Evanston, Illinois (www.blockmd.com). The unit uses research methods of treatment that combine the best Western medicines with additional treatment methods in pharmacology, psychotherapy, meditation, exercise, yoga, etc. D. Block is the chief editor of the peer-reviewed journal Integrative Cancer Therapy, published by SAGE Science Press and indexed in MEDLINE and Index Medicus. He is an assistant professor at the University of Illinois Medical College in Chicago and as an adjunct associate professor of pharmacognosy (the department of pharmacology, which deals with medicine in its natural state and with medicinal herbs and other plants) at the College of Pharmacy at UIC. In addition, Dr. Block is involved in collaborative research with university institutions in the United States and Israel.
